Cambridge Investment Research Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,098	Closed	-$377K	–	3255
2021 Q2	$377K	Buy	+10,098	New	+$377K	﹤0.01%	2287